Research in Genes and Proteins Open Access

A Short Note on Gluten Intolerance in Celiac Disease

Ping Zhou^* Department of Pharmacy, University of Peking, China
^*Correspondence: Ping Zhou, Department of Pharmacy, University of Peking, China, Email:

Received: 01-Mar-2023, Manuscript No. RGP-23-16636; Editor assigned: 03-Mar-2023, Pre QC No. RGP-23-16636 (PQ); Reviewed: 17-Mar-2023, QC No. RGP-23-16636; Revised: 22-May-2023, Manuscript No. RGP-23-16636 (R); Published: 29-Mar-2023, DOI: 10.21767/RGP.4.1.10

Introduction

Celiac disease is an autoimmune disorder triggered by the ingestion of gluten, a protein found in wheat, barley, and rye. This condition affects the small intestine and can lead to a range of symptoms and long-term complications. Celiac disease is more than a simple food intolerance; it is a complex immune response that requires strict adherence to a gluten-free diet. Through advancements in understanding the disease, diagnosis, and dietary management, individuals with celiac disease can lead healthy and fulfilling lives [1]. Celiac disease is characterized by an abnormal immune response to gluten, which triggers inflammation and damage to the small intestine. This immune reaction is primarily directed against an enzyme called tissue transglutaminase, which modifies gluten proteins and leads to the production of antibodies.

Description

When individuals with celiac disease consume gluten-containing foods, the immune system mistakenly attacks the lining of the small intestine, causing damage to the villi tiny finger-like projections responsible for nutrient absorption. This damage can result in malabsorption of essential nutrients, leading to various symptoms and long-term complications if left untreated.

The symptoms of celiac disease can vary widely and may include digestive issues, such as diarrhoea, abdominal pain, bloating, and weight loss [2,3]. However, celiac disease can also manifest as non-gastrointestinal symptoms, including fatigue, anemia, osteoporosis, skin rashes, and neurological problems. Accurate diagnosis of celiac disease involves a combination of blood tests and a confirmatory small intestinal biopsy. Blood tests measure specific antibodies associated with celiac disease, such as anti-tissue transglutaminase antibodies and anti-endomysial antibodies. If the blood tests indicate celiac disease, an endoscopy is performed to obtain small intestinal tissue samples for histological examination.

This involves eliminating all sources of gluten from the diet, including wheat, barley, rye, and cross-contaminated products. Navigating a gluten-free lifestyle can be challenging, as gluten can be present in unexpected food and non-food items. Education, label reading, and support from dietitians and celiac disease support groups are invaluable in successfully managing the dietary aspect of the condition. Despite the restrictions, there are now a wide range of gluten-free alternatives available, including grains like rice, corn, quinoa, and gluten-free versions of bread, pasta, and baked goods [4]. With careful planning and creativity, individuals with celiac disease can enjoy a diverse and balanced diet. Ongoing research aims to further improve the understanding, diagnosis, and management of celiac disease. Researchers are exploring non-dietary therapeutic approaches, such as enzyme therapies and vaccines, which may provide alternative options for individuals with celiac disease.

Conclusion

Additionally, efforts are being made to enhance gluten detection methods and develop gluten-free labeling regulations to ensure the safety of individuals with celiac disease. Celiac disease is a complex autoimmune disorder that requires lifelong commitment to a gluten-free diet. With increased awareness and advancements in research, the understanding and management of celiac disease have significantly improved. By providing accurate diagnosis, education, and support, individuals with celiac disease can embrace a healthy gluten-free lifestyle and prevent long-term complications. Continued research efforts offer hope for further advancements and improved quality of life for those living with celiac disease.

Acknowledgement

None.

Conflict Of Interest

The author’s declared that they have no conflict of interest.

References

1. Gibson PR (2022) Coeliac disease in 2022. Aliment Pharmacol Ther. 1:S1-S2.

   [Crossref] [Google Scholar] [PubMed]

2. Kaukinen K (2021) Updates on systemic consequences of coeliac disease. Nat Rev Gastroenterol Hepatol. 18:87-88.

   [Crossref] [Google Scholar] [PubMed]

3. Niewinski MM (2008) Advances in celiac disease and gluten-free diet. J Am Diet Assoc. 108:661-72.

   [Crossref] [Google Scholar] [PubMed]

4. Mora S (2008) Celiac disease in children: Impact on bone health. Rev Endocr Metab Disord. 9:123-30.

   [Crossref] [Google Scholar] [PubMed]